Namita Thapar's Emcure Pharma IPO - Apply or Avoid? | Emcure Pharmaceuticals IPO Review
Join my WhatsApp channel for daily news updates - [ Ссылка ]
To open a Demat Account, click on the link: [ Ссылка ]
Emcure Pharma is coming up with its Initial Public Offering. The IPO of Emcure Pharmawill open for subscription from July 3, 2024 to July 5, 2024
Emcure Pharma is planning to raise ₹1,952.03 crores via IPO. The issue combines a fresh issue of 0.79 crore shares aggregating to ₹800.00 crores and an offer for sale of 1.14 crore shares aggregating to ₹1,152.03 crores.
In this video, we will review the IPO of Emcure Pharma and analyze its Positives and negatives, GMP, Price, Date and financials.
Should you APPLY or AVOID - the Emcure Pharma IPO?
Watch the video to find out!
Click here to subscribe to my YouTube channel: [ Ссылка ]
To open a Demat Account, click on the link: [ Ссылка ]
My Shooting Gear :
Camera: [ Ссылка ]
Lens: [ Ссылка ]
Microphone: [ Ссылка ]
2nd Microphone - [ Ссылка ]
Tripod - [ Ссылка ]
Bulb Holder - [ Ссылка ]
Softbox - [ Ссылка ]
Key Light 50W- [ Ссылка ]
Fill Light Smart Bulb 12W- [ Ссылка ]
RGB 25W Light Panel- [ Ссылка ]
Connect with me:
Website: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Facebook: [ Ссылка ]
Outcome Theory Podcast: [ Ссылка ]
DISCLAIMER
This content is for educational purposes only. I do not provide tax or investment advice. The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal.
All of the opinions expressed in this video are my own, I was not paid to make this video. Whenever there is a link in any of my videos, if there is a referral program available, please assume that you are clicking on a referral link that will support the channel at no cost to you.
#ipo #upcomingipo #latestipo #EmcurePharmaIPO #EmcurePharmaceuticalsIPO
